Vera Therapeutics

-$0.05 (-0.34%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VERA and other ETFs, options, and stocks.

About VERA

Vera Therapeutics, Inc. is a clinical stage biotechnical company that engages in the development and commercialization of transformative treatments for immunological diseases. Its primary product, atacicept, is a fusion protein self-administered as a subcutaneous injection that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

CEO
Marshall W. Fordyce
Employees
37
Headquarters
Brisbane, California
Founded
2016

VERA Key Statistics

Market cap
401.84M
Price-Earnings ratio
—
Dividend yield
—
Average volume
96.92K
High today
$15.03
Low today
$14.50
Open price
$14.94
Volume
38.47K
52 Week high
$37.11
52 Week low
$13.01

VERA Earnings

-$12.23
-$8.15
-$4.08
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.67 per share
Actual
-$0.71 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure